Ilana Krumm, MD
CLINICAL FELLOW
Medicine
School of Medicine

Awards

Show all (7) Hide

• Medical Education Innovations Grant, Nina Ireland Program for Lung Health, 2023
• Innovations Funding for Education, The Haile T. Debas Academy of Medical Educators, 2023
• Best of ATS Video Lecture Series (BAVLS) Second Place Winner, American Thoracic Society, 2020
• Innovations in Fellowship Education, American Thoracic Society, 2020
• APCCMPD Award Research Grant for Medical Education, CHEST Foundation, 2020
• Medicine Resident Excellence in Teaching Award, University of Washington, 2018
• Alpha Omega Alpha Member, Alpha Omega Alpha Medical Honors Society, 2017

Education & Training

Show all (5) Hide

• Chief Resident University of Washington 2021
• Internal Medicine Residency University of Washington 2020
• Clinician Educator Resident Medical Education University of Washington 2020
• MD University of Washington School of Medicine 2017
• Fellow Pulmonary & Critical Care University of California San Francisco

Websites

Show all (1) Hide

• Teaching Portfolio (ilanakrumm.com)

Publications (8)

Top publication keywords:
Education, MedicalT-Lymphocytes, CytotoxicMelanomaLearningWT1 ProteinsAdoptive TransferInterleukinsVideo RecordingIpilimumabPandemicsCTLA-4 AntigenImmunotherapy, AdoptiveCD8-Positive T-LymphocytesProgrammed Cell Death 1 ReceptorTeaching

• Use of tunneled pleural catheters in chronic empyema: Two case reports and brief review of the literature.
  Respiratory medicine case reports 2022 Krumm IR, Gesthalter YB
• Making Effective Educational Videos for Clinical Teaching.
  Chest 2021 Krumm IR, Miles MC, Clay A, Carlos Ii WG, Adamson R
• Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In Vivo.
  Science immunology 2017 Chapuis AG, Desmarais C, Emerson R, Schmitt TM, Shibuya K, Lai I, Wagener F, Chou J, Roberts IM, Coffey DG, Warren E, Robbins H, Greenberg PD, Yee C
• T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Sloan HL, Lai IP, Farrar EA, Wagener F, Shibuya KC, Cao J, Wolchok JD, Greenberg PD, Yee C
• Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.
  The Journal of experimental medicine 2016 Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Sloan HL, Lai I, Wagener F, Shibuya K, Cao J, Wolchok JD, Greenberg PD, Yee C
• Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
  Nature medicine 2016 Gros A, Parkhurst MR, Tran E, Pasetto A, Robbins PF, Ilyas S, Prickett TD, Gartner JJ, Crystal JS, Roberts IM, Trebska-McGowan K, Wunderlich JR, Yang JC, Rosenberg SA
• Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
  Cancer immunology research 2014 Chapuis AG, Afanasiev OK, Iyer JG, Paulson KG, Parvathaneni U, Hwang JH, Lai I, Roberts IM, Sloan HL, Bhatia S, Shibuya KC, Gooley T, Desmarais C, Koelle DM, Yee C, Nghiem P
• Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.
  Science translational medicine 2013 Chapuis AG, Ragnarsson GB, Nguyen HN, Chaney CN, Pufnock JS, Schmitt TM, Duerkopp N, Roberts IM, Pogosov GL, Ho WY, Ochsenreither S, Wölfl M, Bar M, Radich JP, Yee C, Greenberg PD